LC
IDYA icon

Lindbrook Capital’s IDEAYA Biosciences IDYA Stock Holding History

Lindbrook Capital’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$24K Buy
1,463
+1,012
+224% +$21.6K ﹤0.01% 1282
2024
Q4 		$11.6K Sell
451
-27
-6% -$764 ﹤0.01% 1582
2024
Q3 		$15.1K Sell
478
-13
-3% -$493 ﹤0.01% 1455
2024
Q2 		$17.2K Buy
491
+29
+6% +$1.15K ﹤0.01% 1330
2024
Q1 		$20.3K Buy
462
+4
+0.9% +$172 ﹤0.01% 1202
2023
Q4 		$16.3K Sell
458
-11
-2% -$328 ﹤0.01% 1307
2023
Q3 		$12.7K Buy
469
+12
+3% +$304 ﹤0.01% 1289
2023
Q2 		$10.7K Buy
457
+108
+31% +$2.22K ﹤0.01% 1417
2023
Q1 		$4.79K Buy
349
+134
+62% +$2.23K ﹤0.01% 1866
2022
Q4 		$3.91K Buy
215
+88
+69% +$1.48K ﹤0.01% 1944
2022
Q3 		$2K Buy
+127
New +$1.65K ﹤0.01% 2077

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Lindbrook Capital's IDYA Position: Q1 2025 in Review

Lindbrook Capital increased its IDEAYA Biosciences (IDYA) stake by 224% in Q1 2025, buying an estimated $21.6K and bringing the position to 1,463 shares worth $24K. The position accounts for ﹤0.01% of the portfolio, ranked #1282.

Lindbrook Capital first reported a position in IDYA in Q3 2022 and has held it in 11 quarters since. 207 funds tracked by Wall St. Rank hold IDYA as of Q1 2025.

  • Lindbrook Capital held 1,463 shares of IDEAYA Biosciences worth $24K as of Q1 2025.
  • Lindbrook Capital bought 1,012 IDEAYA Biosciences shares in Q1 2025, an estimated $21.6K.
  • IDEAYA Biosciences made up ﹤0.01% of Lindbrook Capital's portfolio in Q1 2025, its #1282 holding.
  • Lindbrook Capital first reported a position in IDEAYA Biosciences in Q3 2022 and has held it in 11 quarters since.
  • 207 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.